Preclinical pharmacologic properties of dilevalol, an antihypertensive agent possessing selective beta2 agonist-mediated vasodilation and beta antagonism
- 5 June 1989
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 63 (19) , I3-I6
- https://doi.org/10.1016/0002-9149(89)90120-3
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Effects of the Antihypertensive Dilevalol on Aortic Compliance in Anesthetized DogsJournal of Cardiovascular Pharmacology, 1988
- Characterization of Dilevalol Affinity for β- and α-Adrenergic Receptors of Human Cardiovascular TissuesJournal of Cardiovascular Pharmacology, 1988
- Intrinsic .BETA.-sympathomimetic activity of dilevalol, R,R-isomer of labetalol.Journal of Pharmacobio-Dynamics, 1985
- Synthesis and comparison of some cardiovascular properties of the stereoisomers of labetalolJournal of Medicinal Chemistry, 1982
- THE α‐ AND β‐ADRENOCEPTOR BLOCKING POTENCIES OF LABETALOL AND ITS INDIVIDUAL STEREOISOMERS IN ANAESTHETIZED DOGS AND IN ISOLATED TISSUESBritish Journal of Pharmacology, 1982
- Studies on the Mechanism of the Acute Antihypertensive and Vasodilator Actions of Several β-Adrenoceptor AntagonistsJournal of Cardiovascular Pharmacology, 1982